AtriCure Profile

27.91
USD 0.16  0.58%
63%
4%

AtriCure exotic insider transaction detected

AtriCure insider trading alert for general transaction of stock option (right to buy) by Cambridge Stephen S, Vice President; Sales, on June 17, 2018. This event was filed by Atricure Inc with SEC on 2005-11-10. Initial filing of beneficial ownership - SEC Form 3 [view details]   

AtriCure Summary

AtriCure (ATRC) is traded on NASDAQ General Markets in USA. It is located in OHIO, U.S.A and employs 570 people. AtriCure is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 979.02 M. AtriCure conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 35.04 M outstanding shares of which 1.74 M shares are presently shorted by private and institutional investors with about 12.68 trading days to cover. ATRICURE currently holds about 36.04 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check AtriCure Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 27.91HorizonTargetOdds Above 27.91
90.45%30 days 27.91 9.47%
Based on normal probability distribution, the odds of AtriCure to move above current price in 30 days from now is about 9.47% (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fmr LlcCommon Shares5.2 M106.4 M
Wellington Management Group LlpCommon Shares4.6 M93.6 M
View AtriCure Diagnostics

Selected AtriCure Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AtriCure Against Markets

Risk Adjusted
Performance Score (0 to 100)
15 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for AtriCure are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company was founded in 2000 and is headquartered in Mason, Ohio. AtriCure operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets. It employs 570 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameAtriCure
CEO and President and DirectorMichael CarrelView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
LocationOHIO, U.S.A
Business Address7555 Innovation Way
ExchangeNASDAQ General Markets
CIK Number01323885.0
CUSIP04963C209
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.atricure.com
Contact Number513 755 4100
CurrencyUSD - US Dollar

Recommendations

AtriCure Analyst Recommendations
Target PriceAdvice# of Analysts
20.8Buy5Odds
AtriCure current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AtriCure Analyst Advice  

Earnings

AtriCure Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.27April 27, 2017
AtriCure normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

AtriCure Corporate Directors
Michael Hooven Founder and Director
Karen Robards Independent Director, MBA
Regina Groves Independent Director
Check also Trending Equities. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.